News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,970 Results
Type
Article (41420)
Company Profile (268)
Press Release (684270)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (205628)
Career Advice (2035)
Deals (35641)
Drug Delivery (114)
Drug Development (81682)
Employer Resources (173)
FDA (16537)
Job Trends (14999)
News (348221)
Policy (33322)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2596)
Accelerated approval (34)
Adcomms (24)
Allergies (147)
Alliances (49829)
ALS (173)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (314)
Approvals (16806)
Artificial intelligence (520)
Autoimmune disease (159)
Automation (42)
Bankruptcy (361)
Best Places to Work (11665)
BIOSECURE Act (20)
Biosimilars (194)
Biotechnology (174)
Bladder cancer (160)
Brain cancer (57)
Breast cancer (646)
Cancer (4872)
Cardiovascular disease (406)
Career advice (1720)
Career pathing (36)
CAR-T (283)
CDC (46)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (37)
Clinical research (69843)
Collaboration (1722)
Company closure (4)
Compensation (1172)
Complete response letters (58)
COVID-19 (2733)
CRISPR (93)
C-suite (863)
Cystic fibrosis (143)
Data (6304)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (507)
Diagnostics (6730)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (259)
Drug pricing (190)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90642)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (118019)
Executive appointments (983)
FDA (19690)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1484)
Gene editing (199)
Generative AI (44)
Gene therapy (599)
GLP-1 (973)
Government (4943)
Grass and pollen (7)
Guidances (384)
Healthcare (19036)
HIV (63)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (256)
Immuno-oncology (60)
Indications (118)
Infectious disease (3010)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (318)
IPO (16688)
IRA (50)
Job creations (3668)
Job search strategy (1438)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (549)
Leadership (32)
Legal (8017)
Liver cancer (92)
Longevity (15)
Lung cancer (659)
Lymphoma (384)
Machine learning (42)
Management (59)
Manufacturing (809)
MASH (164)
Medical device (13843)
Medtech (13899)
Mergers & acquisitions (20032)
Metabolic disorders (1283)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (322)
Neuropsychiatric disorders (89)
Neuroscience (2935)
Neurotech (1)
NextGen: Class of 2026 (6543)
Non-profit (4559)
Now hiring (68)
Obesity (604)
Opinion (264)
Ovarian cancer (167)
Pain (201)
Pancreatic cancer (230)
Parkinson's disease (286)
Partnered (33)
Patents (507)
Patient recruitment (497)
Peanut (58)
People (59181)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21748)
Phase 2 (30722)
Phase 3 (22932)
Pipeline (5442)
Policy (288)
Postmarket research (2576)
Preclinical (9227)
Press Release (65)
Prostate cancer (241)
Psychedelics (48)
Radiopharmaceuticals (284)
Rare diseases (849)
Real estate (5986)
Recruiting (70)
Regulatory (24830)
Reports (53)
Research institute (2408)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (240)
Series B (191)
Service/supplier (12)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3631)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (86)
The Weekly (54)
Vaccines (1019)
Venture capital (89)
Weight loss (388)
Women's health (93)
Worklife (18)
Date
Last 7 days (565)
Last 30 days (2258)
Last 365 days (29800)
2026 (3989)
2025 (30244)
2024 (35302)
2023 (40170)
2022 (51327)
2021 (55914)
2020 (54363)
2019 (46937)
2018 (35321)
2017 (32266)
2016 (31713)
2015 (37758)
2014 (31487)
2013 (26504)
2012 (28711)
2011 (29398)
2010 (27478)
Location
Africa (751)
Alabama (84)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (39437)
Australia (6468)
California (11403)
Canada (3358)
China (1104)
Colorado (480)
Connecticut (483)
Delaware (341)
Europe (85277)
Florida (1713)
Georgia (361)
Hawaii (3)
Idaho (62)
Illinois (871)
India (70)
Indiana (528)
Iowa (22)
Japan (437)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1395)
Massachusetts (8161)
Michigan (327)
Minnesota (632)
Mississippi (5)
Missouri (135)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (80)
New Jersey (3028)
New Mexico (28)
New York (3005)
North Carolina (1468)
North Dakota (8)
Northern California (5582)
Ohio (337)
Oklahoma (21)
Oregon (41)
Pennsylvania (2307)
Puerto Rico (24)
Rhode Island (48)
South America (1119)
South Carolina (67)
South Dakota (1)
Southern California (4441)
Tennessee (178)
Texas (1755)
United States (40439)
Utah (340)
Vermont (1)
Virginia (265)
Washington D.C. (81)
Washington State (930)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
725,970 Results for "sobi canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II studies.
December 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
December 16, 2025
·
5 min read
Press Releases
Viva Biotech’s invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
December 15, 2025
·
5 min read
Press Releases
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
October 27, 2025
·
16 min read
Press Releases
Teva Canada Announces Strategic Partnership with Novartis Canada to Relaunch Mayzent® for Multiple Sclerosis Patients in Canada
February 2, 2026
·
2 min read
Press Releases
Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
October 2, 2025
·
2 min read
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
Press Releases
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2026
·
4 min read
Press Releases
OraSure to Launch OraQuick™ HIV Self-Test in Canada
February 10, 2026
·
5 min read
Press Releases
Sandoz Canada launches first ophthalmology biosimilar
February 2, 2026
·
3 min read
1 of 72,597
Next
